基于病理生理机制的血栓后综合征生物标志物研究进展
A Review of Biomarker Research for Post-Thrombotic Syndrome Based on Mechanisms of Pathology and Physiology
DOI: 10.12677/acm.2026.162534, PDF,   
作者: 李滨锐, 卜晓青*:重庆医科大学公共卫生学院流行病学教研室,重庆;黄 莹, 李 毅, 刘越琴:重庆医科大学第二附属医院血管外科,重庆
关键词: 血栓后综合征深静脉血栓生物标志物病理生理机制Post-Thrombotic Syndrome Deep Vein Thrombosis Biomarkers Pathophysiological Mechanisms
摘要: 血栓后综合征(PTS)是深静脉血栓(DVT)最常见且严重的长期并发症,目前缺乏有效的早期预测手段。其病理生理机制涉及纤溶功能低下、炎症反应、静脉壁重塑及持续高凝等多个环节。近年来,能够反映上述病理过程的生物标志物在PTS预测中展现出重要潜力,已成为现有临床评估体系的重要补充,也面临特异性不足、检测标准化欠缺等挑战。本综述梳理纤溶系统、炎症反应、静脉重塑及高凝状态四类生物标志物的研究进展;分析其临床证据、应用价值与当前局限,并指出未来应致力于构建联合预测模型、开展动态监测研究及推动检测标准化进程。
Abstract: Post-thrombotic syndrome (PTS) is the most common and serious long-term complication of deep vein thrombosis (DVT), for which there is a lack of effective early prediction. The pathology and physiology mechanism of PTS involves the combination of fibrinolytic function, inflammatory response, venous remodeling and persistent hypercoagulation. In recent years, biomarkers that can objectively reflect pathological processes have shown significant potential in the prediction of PTS. It has become an important supplement to the existing clinical assessment system, whilst still facing challenges in this field such as feasibility and insufficient specificity. This review summarizes the research progress of indicators of fibrinolytic system, inflammatory response, venous remodeling and hypercoagulability; analyses the pathological basis, clinical evidence, application value and current limitations of the four types markers; and it highlights future research directions toward constructing multi-biomarker predictive models, implementing dynamic monitoring, and advancing standardized testing.
文章引用:李滨锐, 黄莹, 李毅, 刘越琴, 卜晓青. 基于病理生理机制的血栓后综合征生物标志物研究进展[J]. 临床医学进展, 2026, 16(2): 1468-1475. https://doi.org/10.12677/acm.2026.162534

参考文献

[1] Ende-Verhaar, Y.M., Tick, L.W., Klok, F.A., Huisman, M.V., Rosendaal, F.R., le Cessie, S., et al. (2019) Post-thrombotic Syndrome: Short and Long-Term Incidence and Risk Factors. Thrombosis Research, 177, 102-109. [Google Scholar] [CrossRef] [PubMed]
[2] 郭倩, 刘丰进, 康海, 等. 参附注射液对脓毒症大鼠血管内皮损伤的影响及机制[J]. 现代中西医结合杂志, 2024, 33(1): 60-65.
[3] Dowling, A.R., Luke, C.E., Cai, Q., Pellerito, A.M., Obi, A.T. and Henke, P.K. (2022) Modulation of Interleukin-6 and Its Effect on Late Vein Wall Injury in a Stasis Mouse Model of Deep Vein Thrombosis. JVS-Vascular Science, 3, 246-255. [Google Scholar] [CrossRef] [PubMed]
[4] 张新瑞, 张珍露, 丁帅, 等. 血清NETs、FIB、miR-374a-5p水平与膝关节置换术后下肢深静脉血栓形成的相关性分析[J]. 中国疗养医学, 2024, 33(1): 25-28.
[5] 深静脉血栓形成的诊断和治疗指南(第三版) [EB/OL].
https://kns.cnki.net/nzkhtml/xmlRead/trialRead.html?dbCode=CJFD&tableName=CJFDTOTAL&fileName=XGWK201704005&fileSourceType=1&appId=KNS_BASIC_PSMC&invoice=KuvIGMOXTnbxweLNFiAZt+KrIYTTJmlRYzACvZw13rGbR8LyVHuxe0Tk+6hlk8raaL2JjtLC6F0u3KdlgczlG5qCOQ+39tcZ+8uW2NaDakZo95o9Ds6ABed2ZaMsxIl2yXVva4rYRseqQPVc3+0MlQcZBbuJr2Wp98Jfd1NDqVM=, 2025-05-18.
[6] Iding, A.F.J., Kremers, B.M.M., Pallares Robles, A., ten Cate, H. and ten Cate-Hoek, A.J. (2023) Residual Venous Obstruction as an Indicator of Clinical Outcomes Following Deep Vein Thrombosis: A Management Study. Thrombosis and Haemostasis, 123, 763-772. [Google Scholar] [CrossRef] [PubMed]
[7] 李才营, 张裕, 赵英海, 等. 下肢深静脉血栓形成治疗前D-二聚体水平测定对血栓后综合征发生的预测作用分析[J]. 中国临床新医学, 2022, 15(10): 951-955.
[8] Bouman, A.C., Atalay, S., ten Cate, H., ten Wolde, M. and ten Cate-Hoek, A.J. (2014) Biomarkers for Post-Thrombotic Syndrome. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2, 79-88.e3. [Google Scholar] [CrossRef] [PubMed]
[9] Rabinovich, A., Cohen, J.M. and Kahn, S.R. (2014) The Predictive Value of Markers of Fibrinolysis and Endothelial Dysfunction in the Post Thrombotic Syndrome: A Systematic Review. Thrombosis and Haemostasis, 111, 1031-1040. [Google Scholar] [CrossRef] [PubMed]
[10] 孙景存, 张洪亮. PAI-1基因4G/5G多态性与下肢深静脉血栓发生风险的相关性分析[J]. 河北医药, 2025, 47(8): 1271-1274, 1278.
[11] 张建军, 靳志雄, 胡常晖, 等. PAI-1基因多态性与血小板聚集率交互作用对下肢深静脉血栓形成的影响[J]. 现代检验医学杂志, 2023, 38(6): 48-53.
[12] Rabinovich, A., Cohen, J.M., Cushman, M., Kahn, S.R., Anderson, D.R., Chagnon, I., et al. (2015) Association between Inflammation Biomarkers, Anatomic Extent of Deep Venous Thrombosis, and Venous Symptoms after Deep Venous Thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 3, 347-353.e1. [Google Scholar] [CrossRef] [PubMed]
[13] 张庆. 血清IL-6、CRP、D-D水平联合检测在下肢深静脉血栓形成患者预后评估中的应用价值[J]. 河南医学研究, 2020, 29(3): 535-537.
[14] 刘建华. 血清CRP、IL-6、D-D水平联合检测在下肢深静脉血栓患者预后评估中的价值[J]. 临床研究, 2018, 26(9): 142-143.
[15] 黄维凤. D-D、CRP及IL-6联合检测对下肢深静脉血栓患者的临床诊断价值分析[J]. 心血管病防治知识, 2024, 14(15): 8-12.
[16] 姜伟光, 党永康, 杨柳, 等. 白细胞介素与深静脉血栓形成关系的研究进展[J]. 血管与腔内血管外科杂志, 2022, 8(5): 573-576.
[17] Lee, K.H., Cavanaugh, L., Leung, H., Yan, F., Ahmadi, Z., Chong, B.H., et al. (2018) Quantification of Nets‐Associated Markers by Flow Cytometry and Serum Assays in Patients with Thrombosis and Sepsis. International Journal of Laboratory Hematology, 40, 392-399. [Google Scholar] [CrossRef] [PubMed]
[18] 杨雪剑, 饶昊杰, 陈虹, 等. 中性粒细胞胞外诱捕网在血栓形成中作用的研究进展[J]. 中国分子心脏病学杂志, 2023, 23(3): 5462-5467.
[19] 吴邮电, 李宁. 老年下肢深静脉血栓患者血清Gas6、IL-1β、NETs水平与介入治疗效果的关系[J]. 检验医学与临床, 2024, 21(4): 515-519.
[20] Rabinovich, A., Cohen, J.M., Cushman, M., Wells, P.S., Rodger, M.A., Kovacs, M.J., et al. (2015) Inflammation Markers and Their Trajectories after Deep Vein Thrombosis in Relation to Risk of Post‐Thrombotic Syndrome. Journal of Thrombosis and Haemostasis, 13, 398-408. [Google Scholar] [CrossRef] [PubMed]
[21] Dzikowska-Diduch, O., Domienik-Karłowicz, J., Górska, E., Demkow, U., Pruszczyk, P. and Kostrubiec, M. (2017) E-selectin and Sicam-1, Biomarkers of Endothelial Function, Predict Recurrence of Venous Thromboembolism. Thrombosis Research, 157, 173-180. [Google Scholar] [CrossRef] [PubMed]
[22] Bittar, L.F., Silva, L.Q.d., Orsi, F.L.d.A., Zapponi, K.C.S., Mazetto, B.d.M., Paula, E.V.d., et al. (2020) Increased Inflammation and Endothelial Markers in Patients with Late Severe Post-Thrombotic Syndrome. PLOS ONE, 15, e0227150. [Google Scholar] [CrossRef] [PubMed]
[23] Borgel, D., Bianchini, E., Lasne, D., Pascreau, T. and Saller, F. (2019) Inflammation in Deep Vein Thrombosis: A Therapeutic Target? Hematology, 24, 742-750. [Google Scholar] [CrossRef] [PubMed]
[24] 姚思成, 慈红波. 血栓性炎症与深静脉血栓形成后综合征相关研究进展[J]. 中国普通外科杂志, 2023, 32(6): 943-949.
[25] de Franciscis, S., Gallelli, L., Amato, B., Butrico, L., Rossi, A., Buffone, G., et al. (2016) Plasma MMP and TIMP Evaluation in Patients with Deep Venous Thrombosis: Could They Have a Predictive Role in the Development of Post‐thrombotic Syndrome? International Wound Journal, 13, 1237-1245. [Google Scholar] [CrossRef] [PubMed]
[26] 李光第, 宋恩, 周如丹, 等. 血小板膜糖蛋白Ⅰbα、血管性血友病因子表达水平与深静脉血栓进展的相关性[J]. 临床检验杂志, 2014, 32(10): 741-745.
[27] Michels, A., Lillicrap, D. and Yacob, M. (2022) Role of Von Willebrand Factor in Venous Thromboembolic Disease. JVS-Vascular Science, 3, 17-29. [Google Scholar] [CrossRef] [PubMed]
[28] 祁莎莎, 曹鑫, 徐宁宁, 等. 深静脉血栓关键基因AP2B1和miRNAs及其相关通路的筛选[J]. 北京生物医学工程, 2022, 41(4): 344-351, 367.
[29] Du, X., Hong, L., Sun, L., Sang, H., Qian, A., Li, W., et al. (2019) miR-21 Induces Endothelial Progenitor Cells Proliferation and Angiogenesis via Targeting FASLG and Is a Potential Prognostic Marker in Deep Venous Thrombosis. Journal of Translational Medicine, 17, Article No. 270. [Google Scholar] [CrossRef] [PubMed]
[30] 霍艳兵, 彭琪, 彭星华, 等. MicroRNA-374a-5p水平与混合型深静脉血栓形成患者临床特征的关系及在预后判断中的价值[J]. 中国现代医学杂志, 2020, 30(19): 23-28.
[31] Zhang, D., Cheng, C., Yang, M., Zhang, X., Yu, X. and Wang, M. (2024) MicroRNA-181b-5p/HEY2 Axis Is Involved in the Progress of Deep Venous Thrombosis via Mediating Vascular Endothelial Injury. Hematology, 29, Article 2423438. [Google Scholar] [CrossRef] [PubMed]
[32] 廖宏伟. 下肢深静脉血栓患者血脂、血清细胞因子、凝血因子的表达水平及其临床意义分析[J]. 中国临床医生杂志, 2022, 50(8): 959-962.
[33] 林毅秋, 丁娣. APCR、ACA、P-selectin的表达与下肢创伤性骨折患者深静脉血栓形成的关系[J]. 创伤外科杂志, 2019, 21(12): 916-919, 924.
[34] 张淑晋, 杨涛, 田宇. 同型半胱氨酸、抗凝血酶Ⅲ、抗心磷脂抗体与下肢深静脉血栓形成后综合征患者预后的相关性分析及预测价值[J]. 血管与腔内血管外科杂志, 2024, 10(9): 1031-1035.
[35] Bittar, L.F., Mazetto, B.d.M., Orsi, F.L.A., Collela, M.P., De Paula, E.V. and Annichino-Bizzacchi, J.M. (2015) Long-Term Increased Factor VIII Levels Are Associated to Interleukin-6 Levels but Not to Post-Thrombotic Syndrome in Patients with Deep Venous Thrombosis. Thrombosis Research, 135, 497-501. [Google Scholar] [CrossRef] [PubMed]
[36] Spiezia, L., Campello, E., Giolo, E., Villalta, S. and Prandoni, P. (2010) Thrombophilia and the Risk of Post‐Thrombotic Syndrome: Retrospective Cohort Observation. Journal of Thrombosis and Haemostasis, 8, 211-213. [Google Scholar] [CrossRef] [PubMed]